Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Dec;35(12):3062–3070. doi: 10.1128/jcm.35.12.3062-3070.1997

Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.

J A Neville 1, L E Prescott 1, V Bhattacherjee 1, N Adams 1, I Pike 1, B Rodgers 1, A El-Zayadi 1, S Hamid 1, G M Dusheiko 1, A A Saeed 1, G H Haydon 1, P Simmonds 1
PMCID: PMC230123  PMID: 9399495

Abstract

Assays that detect antibody to hepatitis C virus (HCV) are used to screen blood donors and patients with hepatitis. Current enzyme-linked immunosorbent assay (ELISA)-based methods are invariably based upon antigens from expressed recombinant proteins or oligopeptides from HCV type 1. Some HCV antigens used in screening assays are coded by regions of the HCV genome that show extensive variability; therefore, HCV type 1-based assays may be less effective for the detection of antibody elicited by infection with other genotypes. In this study, we have measured antibody reactivity of sera from 110 hepatitis C patients infected with type 1b, 3a, or 4a to genotype-specific and cross-reactive epitopes present in recombinant proteins from HCV genotypes 1b (core, NS3, and NS5), 3a (NS3, NS5), and 4a (core, NS3), corresponding to those used in current third-generation screening ELISAs. By comparing the serological reactivities of sera to type-homologous and type-heterologous antigens, we detected a significant type-specific component to the reactivity to NS3 (61 to 77% of the total reactivity) and NS5 (60% of the total reactivity). Furthermore, despite the similarities in the amino acid sequences of the core antigens of type 1b and type 4a, we also found significantly greater reactivity to type-homologous antigens, with approximately 25% of reactivity being type specific. These findings are consistent with previous findings of fivefold weaker reactivity of sera from HCV type 2- and HCV type 3-infected blood donors in the currently used third-generation ELISAs and suggest that these assays are suboptimal for screening populations in which the predominant genotype is not type 1.

Full Text

The Full Text of this article is available as a PDF (221.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhattacherjee V., Prescott L. E., Pike I., Rodgers B., Bell H., El-Zayadi A. R., Kew M. C., Conradie J., Lin C. K., Marsden H. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol. 1995 Jul;76(Pt 7):1737–1748. doi: 10.1099/0022-1317-76-7-1737. [DOI] [PubMed] [Google Scholar]
  2. Cerino A., Bissolati M., Cividini A., Nicosia A., Esumi M., Hayashi N., Mizuno K., Slobbe R., Oudshoorn P., Silini E. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. J Med Virol. 1997 Jan;51(1):1–5. [PubMed] [Google Scholar]
  3. Chamberlain R. W., Adams N., Saeed A. A., Simmonds P., Elliott R. M. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol. 1997 Jun;78(Pt 6):1341–1347. doi: 10.1099/0022-1317-78-6-1341. [DOI] [PubMed] [Google Scholar]
  4. Chan S. W., McOmish F., Holmes E. C., Dow B., Peutherer J. F., Follett E., Yap P. L., Simmonds P. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol. 1992 May;73(Pt 5):1131–1141. doi: 10.1099/0022-1317-73-5-1131. [DOI] [PubMed] [Google Scholar]
  5. Chan S. W., Simmonds P., McOmish F., Yap P. L., Mitchell R., Dow B., Follett E. Serological responses to infection with three different types of hepatitis C virus. Lancet. 1991 Nov 30;338(8779):1391–1391. doi: 10.1016/0140-6736(91)92265-4. [DOI] [PubMed] [Google Scholar]
  6. Chang T. T., Young K. C., Yang Y. J., Lai K. A., Wu H. L., Wu M. H., Chen M. Y., Lin X. Z., Lin C. Y., Shin J. S. Incidence of post-transfusion hepatitis in Taiwan before and after introduction of anti-HCV testing. Liver. 1996 Jun;16(3):201–206. doi: 10.1111/j.1600-0676.1996.tb00728.x. [DOI] [PubMed] [Google Scholar]
  7. Choo Q. L., Richman K. H., Han J. H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P. J. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2451–2455. doi: 10.1073/pnas.88.6.2451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Claeys H., Volckaerts A., Mertens W., Liang Z., Fiten P., Opdenakker G. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus. J Med Virol. 1995 Mar;45(3):273–281. doi: 10.1002/jmv.1890450306. [DOI] [PubMed] [Google Scholar]
  9. Couroucé A. M., Le Marrec N., Girault A., Ducamp S., Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion. 1994 Sep;34(9):790–795. doi: 10.1046/j.1537-2995.1994.34994378281.x. [DOI] [PubMed] [Google Scholar]
  10. Couroucé A. M., Pillonel J. Transfusion-transmitted viral infections. Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion. N Engl J Med. 1996 Nov 21;335(21):1609–1610. doi: 10.1056/NEJM199611213352115. [DOI] [PubMed] [Google Scholar]
  11. Davidson F., Simmonds P., Ferguson J. C., Jarvis L. M., Dow B. C., Follett E. A., Seed C. R., Krusius T., Lin C., Medgyesi G. A. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol. 1995 May;76(Pt 5):1197–1204. doi: 10.1099/0022-1317-76-5-1197. [DOI] [PubMed] [Google Scholar]
  12. Dhaliwal S. K., Prescott L. E., Dow B. C., Davidson F., Brown H., Yap P. L., Follett E. A., Simmonds P. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol. 1996 Feb;48(2):184–190. doi: 10.1002/(SICI)1096-9071(199602)48:2<184::AID-JMV11>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  13. Dixit V., Quan S., Martin P., Larson D., Brezina M., DiNello R., Sra K., Lau J. Y., Chien D., Kolberg J. Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol. 1995 Nov;33(11):2978–2983. doi: 10.1128/jcm.33.11.2978-2983.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dow B. C., Munro H., Buchanan I., Follett E. A., Davidson F., Yap P. L., Simmonds P. Third-generation recombinant immunoblot assay: comparison of reactivities according to hepatitis C virus genotype. Transfusion. 1996 Jun;36(6):547–551. doi: 10.1046/j.1537-2995.1996.36696269515.x. [DOI] [PubMed] [Google Scholar]
  15. González A., Esteban J. I., Madoz P., Viladomiu L., Genesca J., Muñiz E., Enríquez J., Torras X., Hernández J. M., Quer J. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial. Hepatology. 1995 Aug;22(2):439–445. doi: 10.1002/hep.1840220211. [DOI] [PubMed] [Google Scholar]
  16. Jarvis L. M., Watson H. G., McOmish F., Peutherer J. F., Ludlam C. A., Simmonds P. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis. 1994 Oct;170(4):1018–1022. doi: 10.1093/infdis/170.4.1018. [DOI] [PubMed] [Google Scholar]
  17. Kao J. H., Lai M. Y., Hwang Y. T., Yang P. M., Chen P. J., Sheu J. C., Wang T. H., Hsu H. C., Chen D. S. Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay. A clinicopathologic study and demonstration of the usefulness of a third-generation assay. Dig Dis Sci. 1996 Jan;41(1):161–165. doi: 10.1007/BF02208599. [DOI] [PubMed] [Google Scholar]
  18. Lelie P. N., Cuypers H. T., Reesink H. W., van der Poel C. L., Winkel I., Bakker E., van Exel-Oehlers P. J., Vallari D., Allain J. P., Mimms L. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol. 1992 Jul;37(3):203–209. doi: 10.1002/jmv.1890370310. [DOI] [PubMed] [Google Scholar]
  19. Machida A., Ohnuma H., Tsuda F., Munekata E., Tanaka T., Akahane Y., Okamoto H., Mishiro S. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology. 1992 Oct;16(4):886–891. doi: 10.1002/hep.1840160406. [DOI] [PubMed] [Google Scholar]
  20. Makris K., Kouvelis V., Drakopoulos I., Oikonomou E., Maniatis A. Frequency and characteristics of post-transfusion hepatitis in Greece with emphasis on hepatitis C: comparing second- and third-generation assays. Transfus Med. 1995 Sep;5(3):213–224. doi: 10.1111/j.1365-3148.1995.tb00231.x. [DOI] [PubMed] [Google Scholar]
  21. McOmish F., Chan S. W., Dow B. C., Gillon J., Frame W. D., Crawford R. J., Yap P. L., Follett E. A., Simmonds P. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion. 1993 Jan;33(1):7–13. doi: 10.1046/j.1537-2995.1993.33193142314.x. [DOI] [PubMed] [Google Scholar]
  22. Mondelli M. U., Cerino A., Bono F., Cividini A., Maccabruni A., Aricò M., Malfitano A., Barbarini G., Piazza V., Minoli L. Hepatitis C virus (HCV) core serotypes in chronic HCV infection. J Clin Microbiol. 1994 Oct;32(10):2523–2527. doi: 10.1128/jcm.32.10.2523-2527.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Schreiber G. B., Busch M. P., Kleinman S. H., Korelitz J. J. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996 Jun 27;334(26):1685–1690. doi: 10.1056/NEJM199606273342601. [DOI] [PubMed] [Google Scholar]
  24. Simmonds P., McOmish F., Yap P. L., Chan S. W., Lin C. K., Dusheiko G., Saeed A. A., Holmes E. C. Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol. 1993 Apr;74(Pt 4):661–668. doi: 10.1099/0022-1317-74-4-661. [DOI] [PubMed] [Google Scholar]
  25. Simmonds P., Rose K. A., Graham S., Chan S. W., McOmish F., Dow B. C., Follett E. A., Yap P. L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol. 1993 Jun;31(6):1493–1503. doi: 10.1128/jcm.31.6.1493-1503.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Takano S., Nakamura K., Kawai S., Yokosuka O., Satomura Y., Omata M. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis. Hepatology. 1996 Apr;23(4):708–712. doi: 10.1053/jhep.1996.v23.pm0008666321. [DOI] [PubMed] [Google Scholar]
  27. Zein N. N., Rakela J., Persing D. H. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States. Mayo Clin Proc. 1995 May;70(5):449–452. doi: 10.4065/70.5.449. [DOI] [PubMed] [Google Scholar]
  28. Zhang Z. X., Yun Z. B., Chen M., Sönnerborg A., Sällberg M. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction. J Med Virol. 1995 Jan;45(1):50–55. doi: 10.1002/jmv.1890450110. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES